Group A (n = 19) | Group B (n = 15) | p value | |
---|---|---|---|
Indications for IVF/ICSI † | |||
Male factor | 7 (36.8%) | 10 (66.6%) | 0.16 |
Severe OAT | 6 | 8 | |
Mild OAT | 1 | 2 | |
Female factor | 10 (52.6%) | 5 (33.3%) | 0.31 |
Tubal factor | 7 | 4 | |
Repeated abortions | 1 | 0 | |
Others female factors | 2 | 1 | |
Idiopathic factor | 2 (10.5%) | 0 | 0.49 |
Basal characteristics | |||
Age (years) | 31 ± 4.7 | 32 ± 4.8 | 0.74 |
BMI (kg/m2) | 24.0 ± 3.5 | 25.3 ± 2.2 | 0.85 |
Intra-follicular benzene (ng/mL) | 0.15 ± 0.2 | 1.5 ± 1.25 | 0.001 |
Baseline FSH (IU/L) | 5.8 ± 1.1 | 11.3 ± 4.2 | 0.003 |
Baseline LH (IU/L) | 3.9 ± 1.6 | 8.2 ± 2.5 | 0.07 |
IVF/ICSI outcome | |||
Baseline E2 (pg/mL) | 38.9 ± 16.1 | 38.4 ± 18.3 | 0.55 |
E2 peak (pg/mL) | 1836.65 ± 661.9 | 1328.8 ± 493.0 | 0.008 |
Days of stimulation | 13.2 ± 2.7 | 13.4 ± 2.6 | 0.75 |
Gonadotrophin vials | 33.3 ± 15.2 | 32.65 ± 13.8 | 0.59 |
Oocytes retrieved | 7.4 ± 2.5 | 6.6 ± 2.85 | 0.01 |
Embryos transferred | 2.6 ± 0.4 | 2.3 ± 0.6 | 0.04 |
Ongoing pregnancy rate† | 4 (21%) | 4 (28%) | 0.89 |